catalytic [activity of cellular] angiotensin-converting enzyme 2(English)
- recombinant ACE2, BK and COX inhibitor, and LDR in have been considered as treatment options for patients with COVID-19
- sACE2, ACE2, COVID-19, COX, LDR
- Pulmonology, Therapeutic approaches
- https://doi.org…55/2022/8698825